GAITHERSBURG, Md. (WJZ) — Gaithersburg-based company Novavax is working on a potential COVID-19 vaccine, and now, it’s agreeing to supply the shot to Europe.
Novavax will work with Spanish health officials to produce the vaccine for all of Europe.
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
The vaccine is currently in Phase 2 of clinical trials, but is expected to move to Phase 3 in the coming weeks.